Bansisons Tea Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)
Bansisons Tea Industries Ltd · Outcome · 02 Nov 2026, 11:13 pm
Bansisons Tea Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) ■ Revenue: 423 (+145.1% QoQ) ■ EBITDA: -6.7 (-171.0% YoY | -297.6% QoQ) ■ EBITDA Margin (%): -1.6 (-61 bps QoQ) ■ PAT: -3.3 (Profit to Loss YoY | -67.3% QoQ) ■ EPS (INR): -0.05 (-66.7% QoQ) Bansisons Tea Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) Segmental Performance Pharma ■ Revenue: 423 (+145.1% QoQ) ■ EBIT: 3.2 (+148.1% QoQ) ■ EBIT Margin (%): 0.8 (+1 bps QoQ) Real Estate ■ Revenue: 3.7 ■ EBIT: 0.0 ■ EBIT Margin (%): 0.0 Tea Estate ■ Revenue: 0.0 ■ EBIT: 0.0 ■ EBIT Margin (%): 0.0 Unallocable ■ Revenue: 0.0 (-100.0% YoY) ■ EBIT: -6.5 (Profit to Loss YoY | -98.8% QoQ) ■ EBIT Margin (%): 0.0 (-302 bps YoY)
Original exchange filing (PDF)
More announcements from Bansisons Tea Industries Ltd
- Unaudited Financial Results for the quarter ended September 30, 2026 · 02 Nov 2026
- Novyra Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results .... · 02 Nov 2026
- Intimation under Reg 30 · 24 Sept 2026
- Reg 30 · 22 Aug 2026
- Quarterly Results June 30, 2026 · 14 Aug 2026
- Quarterly Results June 30, 2026 · 14 Aug 2026
- Bansisons Tea Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Quarterly Results June 30, 2026 · 14 Aug 2026
- Change of Website · 04 Aug 2026
